60 Degrees Pharmaceuticals I
13F holders, Q4 2025 (December 31)7holders
2new positions
2sold out
$0.51avg. 13F price*
At the end of Q4 2025, 7 institutions reported holding 60 Degrees Pharmaceuticals I in their 13F filings, unchanged from Q3 2025. 2 opened new positions and 2 sold out. The largest holders were Jane Street Group, LLC ($11K), Geode Capital Management, LLC ($6K) and Tower Research Capital LLC (TRC) ($3K).
- Company
- 60 Degrees Pharmaceuticals I
- CUSIP
- 83006G401
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $12K |
| Exits | 2 | $38K |
All 13F filers, Q3 2025 → Q4 2025: 27,163 shares bought and 25,400 shares sold, net +1,763 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Jane Street Group, LLC | 0.00% | New | 22,051 | $11K |
| Geode Capital Management, LLC | 0.00% | No change | 12,449 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +114.6% | 6,738 | $3K |
| Barclays PLC | 0.00% | New | 1,513 | $769 |
| UBS Group AG | 0.00% | No change | 1,476 | $750 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $51 |
| Bank of America Corp. | 0.00% | Add +3.3% | 31 | $16 |
"% of holder's portfolio" is 60 DEGREES PHARMACEUTICALS I's weight in each manager's 13F, not the share of 60 Degrees Pharmaceuticals I the manager owns.